Institutional investors purchased a net $198.9 thousand shares of OHRP during the quarter ended June 2014. This may signal that the smart money is gaining interest in this company as the 36.07% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NORTHERN TRUST INVESTMENTS, INC. Bought 161.4 Thousand shares of OHR Pharmaceutical Inc